Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.754
AS - Asia 8.344
EU - Europa 8.126
SA - Sud America 1.077
AF - Africa 155
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 17
Totale 31.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.328
SG - Singapore 2.558
IT - Italia 2.277
CN - Cina 1.973
VN - Vietnam 1.691
DE - Germania 1.299
RU - Federazione Russa 1.076
HK - Hong Kong 944
BR - Brasile 864
SE - Svezia 812
IE - Irlanda 576
GB - Regno Unito 459
UA - Ucraina 361
CA - Canada 326
IN - India 288
FI - Finlandia 235
FR - Francia 189
ID - Indonesia 168
AT - Austria 149
PL - Polonia 148
KR - Corea 136
DK - Danimarca 116
JP - Giappone 94
NL - Olanda 94
AR - Argentina 85
ZA - Sudafrica 81
TR - Turchia 80
ES - Italia 76
BD - Bangladesh 68
MX - Messico 67
IR - Iran 55
BE - Belgio 54
IQ - Iraq 46
TW - Taiwan 43
PT - Portogallo 33
PK - Pakistan 31
RO - Romania 29
AU - Australia 27
EC - Ecuador 25
BG - Bulgaria 24
CO - Colombia 22
UZ - Uzbekistan 22
CH - Svizzera 21
GR - Grecia 21
CZ - Repubblica Ceca 20
LT - Lituania 20
VE - Venezuela 20
IL - Israele 19
CL - Cile 18
PY - Paraguay 18
SA - Arabia Saudita 16
JO - Giordania 15
KE - Kenya 15
MY - Malesia 15
EU - Europa 14
EG - Egitto 13
MA - Marocco 11
NP - Nepal 11
HU - Ungheria 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
UY - Uruguay 9
AZ - Azerbaigian 8
HN - Honduras 7
PH - Filippine 7
ET - Etiopia 6
KZ - Kazakistan 6
OM - Oman 6
AL - Albania 5
BB - Barbados 5
LB - Libano 5
MU - Mauritius 5
PA - Panama 5
TN - Tunisia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LY - Libia 2
NG - Nigeria 2
Totale 31.482
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.569
Ashburn 1.367
Hong Kong 917
Milan 912
Woodbridge 866
Frankfurt am Main 711
Fairfield 670
Chandler 632
Houston 576
Wilmington 567
Dublin 556
Ho Chi Minh City 507
Hanoi 400
Dearborn 370
Jacksonville 357
Beijing 350
Santa Clara 333
Dallas 331
Seattle 327
New York 307
Los Angeles 247
Cambridge 246
Hefei 194
Princeton 191
Nanjing 165
Jakarta 145
Shanghai 124
Vienna 123
Helsinki 108
São Paulo 98
Buffalo 92
Chicago 92
Toronto 89
The Dalles 88
Moscow 87
Guangzhou 85
Seoul 85
Kraków 74
Lawrence 72
Munich 70
Council Bluffs 68
San Diego 63
Altamura 62
Dong Ket 62
Tokyo 62
Warsaw 61
Ottawa 59
Lachine 58
Nanchang 55
Fremont 53
Denver 52
Rome 51
Brussels 50
London 46
Melzo 46
Haiphong 45
Nuremberg 44
Montreal 43
Wayne 43
Da Nang 42
Hangzhou 42
Johannesburg 41
Orem 40
Chennai 39
Ha Long 39
Kunming 39
Changsha 37
Pune 37
Boardman 36
Boston 35
Monza 35
Phoenix 35
Poplar 35
Stockholm 35
Andover 33
Shenyang 32
Brooklyn 31
Turku 31
Zhengzhou 31
Atlanta 30
Hebei 30
Biên Hòa 29
Hải Dương 29
Mumbai 27
Tianjin 27
Bắc Ninh 26
Kent 26
Nürnberg 26
Thái Nguyên 26
Bologna 25
Grafing 25
Ankara 24
Can Tho 24
Genoa 24
Norwalk 24
San Jose 24
Como 23
Ninh Bình 23
Columbus 22
Totale 20.150
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 642
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 589
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 531
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 518
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 477
A new approach for glyco-functionalization of collagen-based biomaterials 470
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 469
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 466
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 464
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 463
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 462
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 425
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 423
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 422
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 418
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 408
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 400
Phage-displayed peptides targeting specific tissues and organs 392
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 391
Nanomedicine for the treatment of Alzheimer's disease 383
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 374
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 367
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 363
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 349
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 348
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 347
Enhanced brain targeting of engineered solid lipid nanoparticles 341
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 336
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 334
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 327
Are the nanoparticles friends or foes when inhaled? 327
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 322
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 315
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 312
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 308
TrkA pathway activation induced by amyloid-beta (Abeta) 305
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 300
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 296
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 290
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 289
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 288
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 287
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 283
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 279
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 279
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 278
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 277
Effect of modified collagen on amyloid beta peptide aggregation 272
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 272
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 270
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 270
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 265
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 261
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 260
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 257
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 254
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 254
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 250
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 249
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 246
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 245
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 242
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 241
Enhanced brain targeting of engineered solid lipid nanoparticles 238
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 237
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 234
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 231
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 230
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 228
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 223
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 220
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 216
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 213
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 212
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 211
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 211
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 210
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 208
Nanotechnology for neurodegenerative disorders 207
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 205
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 205
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 205
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 204
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 203
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 202
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 201
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 195
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 194
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 194
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 189
Nanotechnology for neurodegenerative disorders 187
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 185
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 183
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 183
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 180
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 177
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 177
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 177
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 174
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 174
Totale 29.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.950 0 0 0 0 0 277 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/20268.788 2.445 987 1.230 1.650 1.851 625 0 0 0 0 0 0
Totale 32.427